Svetlana A. Terekhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Svetlana A. Terekhova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Aleksander F. Lazarev
Altai State Medical University, Ministry of Health of Russia
6 shared publications - Dmitriy I. Ganov
Altai State Medical University
5 shared publications - Valentina D. Petrova
Altai State Medical University
5 shared publications - Irina M. Zakharova
Altai Regional Oncology Dispensary, Ministry of Health of Russia; Altai State Medical University, Ministry of Health of Russia
3 shared publications - Julia A. Antonova
Altai State Medical University
3 shared publications - Ilya S. Osipov2 shared publications
Latest Publications
- Open Access
- 9 July 2025
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (2) , 75-84
Prognostic significance of the Bethesda cytological classification in recurrent thyroid carcinoma
Introduction. The Bethesda System for Reporting Thyroid Cytopathology allows to standardize interpretation of fine needle aspiration biopsy of thyroid nodules with assessment of suspected malignancy risk. Analysis of prognostic significance of cytological data, using the Bethesda System as an example, is necessary for determination of tumor process aggressiveness and possibility of development of recurrences.Aim. To study prognostic significance of the Bethesda System for Reporting Thyroid Cytopathology in recurrent thyroid carcinoma.Materials and methods. Results of examinations and surgical interventions performed at the Altai Regional Oncological Dispensary (Barnaul) during a 3-year period in 503 patients (423 women (84.1 %) and 80 (15.9 %) men) with thyroid carcinoma are analyzed. In 440 patients, thyroid carcinoma in surgical material was found for the first time (R0 – primary patients); in 63 patients, disease recurrence was diagnosed (R1 – presence of recurrence). At the time of surgery, median patient age was 51 years (interquartile range 40–62 years). The inclusion criterion for the study was morphologically confirmed diagnosis of thyroid carcinoma; the exclusion criterion was the absence of cytological examination per the Bethesda System in patients with recurrent carcinoma. Data from medical records, disease histories and cancer registry were evaluated taking into account clinical and anamnestic characteristics of a special classifier for determination of risk factors of disease recurrence. Data processing was performed using Microsoft Excel software. At the preoperative stage, in primary patients, results of ultrasound and cytological examination of the fine needle aspiration biopsy of thyroid nodules were analyzed. Results of cytological examination per the Bethesda System were considered as an independent risk factor of recurrence. Orange Data Mining (version 3.3.37.0) and RStudio (version 4.3.1) software were used for data analysis. Distributions of quantitative variables were evaluated using the Kolmogorov–Smirnov and Shapiro–Wilk tests. Normal distribution hypothesis was rejected at p 0.20 for Kolmogorov–Smirnov test and at p 0.05 for Shapiro–Wilk test.Results. According to the data, median time to recurrence was 2 years (Q1–Q3 – 1–6 years), minimal time to its development was 1 year, maximal – 20 years. 1-year recurrence-free survival was 100 %, 3-year was 91 %, 5-year was 86 %, 10-year was 59 %, 15-year was 25 %. Mean time to recurrence in 50 % of patients was 9.8 ± 0.9 years. Risk of recurrence of thyroid carcinoma of category IV per the Bethesda System was 3.623 times (72.4 %) lower compared to category III (hazard ratio 0.276; 95 % confidence interval 0.110–0.691; p = 0.006). Recurrence-free survival in patients with thyroid carcinoma of category VI per the Bethesda System was significantly higher (р = 0003 and p 0.001) than in patients with category III and IV cytopathology.Conclusion. Cytological conclusion of category III per the Bethesda System is 2.755 times more common in recurrence group than of category VI. Category VI cytopathology, 88.7 % of which are papillary thyroid carcinoma with conclusive cell signs, is characterized by relatively low risk of recurrence. Cytologic conclusion of categories III and IV per the Bethesda System is an unfavorable prognostic factor in preoperative diagnostics due to undetermined interpretation of the pathology. These categories are commonly observed in patients with more aggressive disease progression.
- 9 July 2025
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (2) , 75-84
Open AccessPrognostic significance of the Bethesda cytological classification in recurrent thyroid carcinoma
Introduction. The Bethesda System for Reporting Thyroid Cytopathology allows to standardize interpretation of fine needle aspiration biopsy of thyroid nodules with assessment of suspected malignancy risk. Analysis of prognostic significance of cytological data, using the Bethesda System as an example, is necessary for determination of tumor process aggressiveness and possibility of development of recurrences.Aim. To study prognostic significance of the Bethesda System for Reporting Thyroid Cytopathology in recurrent thyroid carcinoma.Materials and methods. Results of examinations and surgical interventions performed at the Altai Regional Oncological Dispensary (Barnaul) during a 3-year period in 503 patients (423 women (84.1 %) and 80 (15.9 %) men) with thyroid carcinoma are analyzed. In 440 patients, thyroid carcinoma in surgical material was found for the first time (R0 – primary patients); in 63 patients, disease recurrence was diagnosed (R1 – presence of recurrence). At the time of surgery, median patient age was 51 years (interquartile range 40–62 years). The inclusion criterion for the study was morphologically confirmed diagnosis of thyroid carcinoma; the exclusion criterion was the absence of cytological examination per the Bethesda System in patients with recurrent carcinoma. Data from medical records, disease histories and cancer registry were evaluated taking into account clinical and anamnestic characteristics of a special classifier for determination of risk factors of disease recurrence. Data processing was performed using Microsoft Excel software. At the preoperative stage, in primary patients, results of ultrasound and cytological examination of the fine needle aspiration biopsy of thyroid nodules were analyzed. Results of cytological examination per the Bethesda System were considered as an independent risk factor of recurrence. Orange Data Mining (version 3.3.37.0) and RStudio (version 4.3.1) software were used for data analysis. Distributions of quantitative variables were evaluated using the Kolmogorov–Smirnov and Shapiro–Wilk tests. Normal distribution hypothesis was rejected at p 0.20 for Kolmogorov–Smirnov test and at p 0.05 for Shapiro–Wilk test.Results. According to the data, median time to recurrence was 2 years (Q1–Q3 – 1–6 years), minimal time to its development was 1 year, maximal – 20 years. 1-year recurrence-free survival was 100 %, 3-year was 91 %, 5-year was 86 %, 10-year was 59 %, 15-year was 25 %. Mean time to recurrence in 50 % of patients was 9.8 ± 0.9 years. Risk of recurrence of thyroid carcinoma of category IV per the Bethesda System was 3.623 times (72.4 %) lower compared to category III (hazard ratio 0.276; 95 % confidence interval 0.110–0.691; p = 0.006). Recurrence-free survival in patients with thyroid carcinoma of category VI per the Bethesda System was significantly higher (р = 0003 and p 0.001) than in patients with category III and IV cytopathology.Conclusion. Cytological conclusion of category III per the Bethesda System is 2.755 times more common in recurrence group than of category VI. Category VI cytopathology, 88.7 % of which are papillary thyroid carcinoma with conclusive cell signs, is characterized by relatively low risk of recurrence. Cytologic conclusion of categories III and IV per the Bethesda System is an unfavorable prognostic factor in preoperative diagnostics due to undetermined interpretation of the pathology. These categories are commonly observed in patients with more aggressive disease progression.
- Open Access
- 23 June 2025
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 30 (1) , 31-40
Analysis of Thyroid Cancer Incidence Trends in Altai Krai Focusing on the Impact of Papillary Microcarcinomas on Morbidity Structure
BACKGROUND: In recent years, the incidence of thyroid cancer has been increasing, primarily due to the rising detection of papillary microcarcinomas (T1a). However, the mortality rates have not declined. This study is devoted to evaluate trends in thyroid cancer incidence in Altai Krai, with a particular focus on the T1a subcategory. AIM: The work aimed to study the trends of thyroid cancer incidence in Altai Krai in 2014–2023, with a focus on tumors at the papillary microcarcinoma stage (T1a), including their recurrence rates. METHODS: Data from the regional cancer registry were used. Incidence rates, stage distribution, histological structure, and recurrence rates were assesed. The data were than compared to those from across Russia, along with the international data on active observation. RESULTS: The incidence rate in the region was 3–4 times higher than the average rate in Russia. Stage T1 accounted for 66.4% of cases, with T1a representing 36.1%. The recurrence rate of papillary microcarcinomas remained below 4%, with a declining trend reaching 0.35% in 2023. CONCLUSION: The high proportion of early-stage tumors and the low recurrence rate of papillary microcarcinomas highlight the potential for incorporating active surveillance strategies into Russian clinical practice.
- 23 June 2025
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 30 (1) , 31-40
Open AccessAnalysis of Thyroid Cancer Incidence Trends in Altai Krai Focusing on the Impact of Papillary Microcarcinomas on Morbidity Structure
BACKGROUND: In recent years, the incidence of thyroid cancer has been increasing, primarily due to the rising detection of papillary microcarcinomas (T1a). However, the mortality rates have not declined. This study is devoted to evaluate trends in thyroid cancer incidence in Altai Krai, with a particular focus on the T1a subcategory. AIM: The work aimed to study the trends of thyroid cancer incidence in Altai Krai in 2014–2023, with a focus on tumors at the papillary microcarcinoma stage (T1a), including their recurrence rates. METHODS: Data from the regional cancer registry were used. Incidence rates, stage distribution, histological structure, and recurrence rates were assesed. The data were than compared to those from across Russia, along with the international data on active observation. RESULTS: The incidence rate in the region was 3–4 times higher than the average rate in Russia. Stage T1 accounted for 66.4% of cases, with T1a representing 36.1%. The recurrence rate of papillary microcarcinomas remained below 4%, with a declining trend reaching 0.35% in 2023. CONCLUSION: The high proportion of early-stage tumors and the low recurrence rate of papillary microcarcinomas highlight the potential for incorporating active surveillance strategies into Russian clinical practice.
- Open Access
- 4 March 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 86-98
Possible risk factors for thyroid cancer (on the example of Altai Territory residents)
Purpose of the study. To study the prognostic significance of various exogenous and endogenous risk factors for thyroid cancer (TC). Materials and methods. The influence of various exogenous and endogenous factors, as well as anamnestic data, as indirect predictors of the development of TC, was studied in 1463 patients: in the main group, which included 505 patients with a verified diagnosis of TC and a control group formed by a continuous method, 958 people were free from MNs. Statistical data processing was performed using Orange Data Mining software (3–3.37.0) and RStudio (version 4.3.1). The character of the distribution of quantitative variables was assessed using the Kolmogorov–Smirnov and Shapiro–Wilk criteria. When using the Kolmogorov–Smirnov criterion, the hypothesis of the normality of the distribution is rejected at p < 0.20, when using the Shapiro–Wilk criterion – at p < 0.05. Results. A comparative analysis showed a statistically significant association of a number of factors with the development of TC: female sex and age over 51 years, an overwhelming hereditary history, occupational hazards, mental work, surgery and chronic thyroid diseases, impaired homeostasis, and others, a total of 28 factors (p < 0.001). Factors preventing the development of TC were identified: male gender and age 45 years and younger, physical labor, melancholic temperament, sleep duration of more than 7 hours (p < 0.001). Factors such as smoking, alcohol intake, and iodized salt did not have a statistically significant effect when comparing the studied groups in the Altai Territory. Conclusion. The conducted research allowed us to identify significant factors contributing to and hindering the development of TC. It has been established that none of the risk factors has an independent decisive significance, and therefore it is necessary to calculate the total risk according to the original formula, which will determine the personalized risk of developing TC and targeted prevention measures.
- 4 March 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 86-98
Open AccessPossible risk factors for thyroid cancer (on the example of Altai Territory residents)
Purpose of the study. To study the prognostic significance of various exogenous and endogenous risk factors for thyroid cancer (TC). Materials and methods. The influence of various exogenous and endogenous factors, as well as anamnestic data, as indirect predictors of the development of TC, was studied in 1463 patients: in the main group, which included 505 patients with a verified diagnosis of TC and a control group formed by a continuous method, 958 people were free from MNs. Statistical data processing was performed using Orange Data Mining software (3–3.37.0) and RStudio (version 4.3.1). The character of the distribution of quantitative variables was assessed using the Kolmogorov–Smirnov and Shapiro–Wilk criteria. When using the Kolmogorov–Smirnov criterion, the hypothesis of the normality of the distribution is rejected at p < 0.20, when using the Shapiro–Wilk criterion – at p < 0.05. Results. A comparative analysis showed a statistically significant association of a number of factors with the development of TC: female sex and age over 51 years, an overwhelming hereditary history, occupational hazards, mental work, surgery and chronic thyroid diseases, impaired homeostasis, and others, a total of 28 factors (p < 0.001). Factors preventing the development of TC were identified: male gender and age 45 years and younger, physical labor, melancholic temperament, sleep duration of more than 7 hours (p < 0.001). Factors such as smoking, alcohol intake, and iodized salt did not have a statistically significant effect when comparing the studied groups in the Altai Territory. Conclusion. The conducted research allowed us to identify significant factors contributing to and hindering the development of TC. It has been established that none of the risk factors has an independent decisive significance, and therefore it is necessary to calculate the total risk according to the original formula, which will determine the personalized risk of developing TC and targeted prevention measures.
- Open Access
- 25 December 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (4) , 344-357
Microbiome and Human Cancer: Descriptive Literature Review
The term “microbiome” is defined as the community of all microorganisms and their metabolic byproducts within their environment. It also refers to the complete set of genetic material and the relationships between these microorganisms within a specific ecological setting throughout a certain period of time. The human microbiome profile develops from birth and remains relatively stable throughout adult life. The microbiota’s primary functions include involvement in the most essential processes of the body’s vital activity, such as the development of adaptive mechanisms, immune defense, physiological homeostasis, cognitive function, and regulation of energy resources within the body. Consequently, the microbiota plays a pivotal role in preserving equilibrium within the macroorganism itself and between the macroorganism and its environment. This article presents the findings of numerous scientific investigations that examine the impact of microbiota on the vital activity of tumors. These studies demonstrate that the microbiota can either accelerate or decelerate tumor growth, and in certain instances, the bacterial community does not contribute to the development of tumors. Tumors, characterized by the profound cellular changes resulting from the impairment of essential DNA mechanisms, create a specific environment that fosters bacterial colonization. In general, tumor tissue is known to have a higher bacterial load compared to normal tissue. Bacteria have been observed to produce certain metabolites that are subsequently used by tumor cells. Consequently, these bacteria and tumor cells compete directly for nutrients essential to their vital functions. The study examines the conditions underlying a particular scenario in which tumors and microbiota may interact. The review presents findings from studies that have sought to regulate intratumor microbes as a potential new target for anti-cancer therapy. This includes the use of bacterial platforms and fecal microbiota transplantation. Additionally, this study presents investigational findings concerning the use of microbiota in the treatment of acute respiratory viral infection, with a focus on chemotherapeutic and immunotherapeutic protocols. These findings corroborate the efficacy of microbiota-based interventions and concurrently highlight the potential for adverse complications.
- 25 December 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 29 (4) , 344-357
Open AccessMicrobiome and Human Cancer: Descriptive Literature Review
The term “microbiome” is defined as the community of all microorganisms and their metabolic byproducts within their environment. It also refers to the complete set of genetic material and the relationships between these microorganisms within a specific ecological setting throughout a certain period of time. The human microbiome profile develops from birth and remains relatively stable throughout adult life. The microbiota’s primary functions include involvement in the most essential processes of the body’s vital activity, such as the development of adaptive mechanisms, immune defense, physiological homeostasis, cognitive function, and regulation of energy resources within the body. Consequently, the microbiota plays a pivotal role in preserving equilibrium within the macroorganism itself and between the macroorganism and its environment. This article presents the findings of numerous scientific investigations that examine the impact of microbiota on the vital activity of tumors. These studies demonstrate that the microbiota can either accelerate or decelerate tumor growth, and in certain instances, the bacterial community does not contribute to the development of tumors. Tumors, characterized by the profound cellular changes resulting from the impairment of essential DNA mechanisms, create a specific environment that fosters bacterial colonization. In general, tumor tissue is known to have a higher bacterial load compared to normal tissue. Bacteria have been observed to produce certain metabolites that are subsequently used by tumor cells. Consequently, these bacteria and tumor cells compete directly for nutrients essential to their vital functions. The study examines the conditions underlying a particular scenario in which tumors and microbiota may interact. The review presents findings from studies that have sought to regulate intratumor microbes as a potential new target for anti-cancer therapy. This includes the use of bacterial platforms and fecal microbiota transplantation. Additionally, this study presents investigational findings concerning the use of microbiota in the treatment of acute respiratory viral infection, with a focus on chemotherapeutic and immunotherapeutic protocols. These findings corroborate the efficacy of microbiota-based interventions and concurrently highlight the potential for adverse complications.
- 11 January 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 27 (6) , 255-265
Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors
BACKGROUND: To date, there are no effective methods for early diagnosis and screening of breast cancer. High-tech methods, such as magnetic resonance imaging and contrasted computed tomography, as well as positron emission computed tomography have high resolution, but their high cost does not allow the use of these techniques for screening and primary diagnosis. AIM: To improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach based on an analysis of a set of risk factors. MATERIALS AND METHODS: Data from the population cancer registry of the Altai Territory, created at the Altai Regional Oncology Center (Barnaul, Russia), were used. To date, the register includes information on 308 550 patients with malignant neoplasms, including 31 783 women with breast cancer. Based on the method of targeted prevention by A.F. Lazarev “Method for determining the risk of breast cancer according to Lazarev A.F.” (Patent No. 2651131) an “Automated program for early diagnosis of breast cancer” was developed. The program significantly reduces the time for the formation of groups of high cancer risk precancers and increases the efficiency of breast cancer detection, and also makes it possible to develop a set of targeted preventive measures personally for each patient. Testing of this algorithm included testing of 512 patients, as a result of which a high-risk precancer group was formed. In the established register, patients underwent a complex of in-depth examinations (ultrasound examination, mammography, magnetic resonance imaging with dynamic contrast, and puncture of tumors if indicated). RESULTS: The precancer group at high risk of developing breast cancer consisted of 92 patients, in-depth examination revealed 7 patients with established breast cancer, which amounted to 7.6%. All cases of breast cancer were detected in stages I and II. CONCLUSION: Targeted diagnostics using the “Automated program for early diagnosis of breast cancer” allows to improve the quality and efficiency of diagnostic measures for breast cancer identification through personalized approach, using multiple risk factors.
- 11 January 2024
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 27 (6) , 255-265
Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors
BACKGROUND: To date, there are no effective methods for early diagnosis and screening of breast cancer. High-tech methods, such as magnetic resonance imaging and contrasted computed tomography, as well as positron emission computed tomography have high resolution, but their high cost does not allow the use of these techniques for screening and primary diagnosis. AIM: To improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach based on an analysis of a set of risk factors. MATERIALS AND METHODS: Data from the population cancer registry of the Altai Territory, created at the Altai Regional Oncology Center (Barnaul, Russia), were used. To date, the register includes information on 308 550 patients with malignant neoplasms, including 31 783 women with breast cancer. Based on the method of targeted prevention by A.F. Lazarev “Method for determining the risk of breast cancer according to Lazarev A.F.” (Patent No. 2651131) an “Automated program for early diagnosis of breast cancer” was developed. The program significantly reduces the time for the formation of groups of high cancer risk precancers and increases the efficiency of breast cancer detection, and also makes it possible to develop a set of targeted preventive measures personally for each patient. Testing of this algorithm included testing of 512 patients, as a result of which a high-risk precancer group was formed. In the established register, patients underwent a complex of in-depth examinations (ultrasound examination, mammography, magnetic resonance imaging with dynamic contrast, and puncture of tumors if indicated). RESULTS: The precancer group at high risk of developing breast cancer consisted of 92 patients, in-depth examination revealed 7 patients with established breast cancer, which amounted to 7.6%. All cases of breast cancer were detected in stages I and II. CONCLUSION: Targeted diagnostics using the “Automated program for early diagnosis of breast cancer” allows to improve the quality and efficiency of diagnostic measures for breast cancer identification through personalized approach, using multiple risk factors.
- 22 December 2023
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 28 (2) , 109-118
Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors
BACKGROUND: There is a trend of increasing incidence and mortality from prostate cancer. Existing methods for early diagnosis and screening of prostate cancer did not demonstrate enough efficiency. AIM: To improve the quality and efficiency of diagnostic measures for prostate cancer through a personalized approach to patients based on an analysis of a set of risk factors. MATERIALS AND METHODS: The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308 550 patients with malignant neoplasms, including 15 167 males with prostate cancer. On the basis of the method of prostate cancer risk assessment proposed by Lazarev AF an automated program for early diagnosis of prostate cancer has been developed. Testing of this technique included assessment of 532 patients (aged between 23 and 82). RESULTS: 128 patients were determined to belong to the high risk pre-cancer group. A high-risk precancer registry was created, which included the patients having individual risk of developing prostate cancer either increased or high or absolute. Upon a set of in-depth examinations, 7 of 128 patients (9.3%) were diagnosed with prostate cancer, all at early stages (I or II). Thus, the incidence of prostate cancer among the patients from the high risk pre-cancer registry was significantly higher than the average observed during prophylactic examinations (0.01%). CONCLUSION: The automated program for early diagnosis of prostate cancer could be implemented with the aim to assign in-depth examination in more targeted manner to patients at high risk of prostate cancer and to contribute to detection the cancer in the early stages.
- 22 December 2023
- Published by ECO-Vector LLC in Russian Journal of Oncology
- Vol. 28 (2) , 109-118
Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors
BACKGROUND: There is a trend of increasing incidence and mortality from prostate cancer. Existing methods for early diagnosis and screening of prostate cancer did not demonstrate enough efficiency. AIM: To improve the quality and efficiency of diagnostic measures for prostate cancer through a personalized approach to patients based on an analysis of a set of risk factors. MATERIALS AND METHODS: The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308 550 patients with malignant neoplasms, including 15 167 males with prostate cancer. On the basis of the method of prostate cancer risk assessment proposed by Lazarev AF an automated program for early diagnosis of prostate cancer has been developed. Testing of this technique included assessment of 532 patients (aged between 23 and 82). RESULTS: 128 patients were determined to belong to the high risk pre-cancer group. A high-risk precancer registry was created, which included the patients having individual risk of developing prostate cancer either increased or high or absolute. Upon a set of in-depth examinations, 7 of 128 patients (9.3%) were diagnosed with prostate cancer, all at early stages (I or II). Thus, the incidence of prostate cancer among the patients from the high risk pre-cancer registry was significantly higher than the average observed during prophylactic examinations (0.01%). CONCLUSION: The automated program for early diagnosis of prostate cancer could be implemented with the aim to assign in-depth examination in more targeted manner to patients at high risk of prostate cancer and to contribute to detection the cancer in the early stages.